Foghorn Therapeutics Inc. Balance Sheet

Balance Sheet Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Current Assets
Cash & Equivalents 92.80M101.14M52.21M80.34M55.45M
Receivables - Other 300.00M
Prepaid Assets 4.92M5.27M5.60M6.12M5.85M
Current Assets 190.69M459.56M351.40M240.18M249.60M
Non-Current Assets
Property, Plant & Equipment (Net) 19.53M17.56M15.31M12.96M9.96M
Other Non-Current Assets 1.73M2.40M2.38M1.71M1.71M
Non-Current Assets 64.91M60.21M53.48M45.73M34.38M
Assets 255.59M519.77M404.88M285.92M283.98M
Liabilities
Current Liabilities
Accounts Payables 9.16M9.56M11.00M9.11M8.53M
Payables 9.16M9.56M11.00M9.11M8.53M
Accumulated Expenses 9.16M9.56M11.00M9.11M8.53M
Other Accumulated Expenses 0.14M0.39M0.32M0.04M0.00M
Current Leases 3.98M6.99M5.97M8.52M9.07M
Current Deferred Revenue 2.02M28.32M32.82M34.55M45.61M
Total Current Liabilities 18.85M48.69M55.20M58.44M66.99M
Non-Current Liabilities
Non-Current Debt 19.65M
Non-Current Deffered Revenue 12.55M322.73M304.00M268.12M234.46M
Operating Leases 62.34M58.33M51.51M45.07M28.06M
Other Non-Current Liabilities 0.14M0.03M
Total Non-Current Liabilities 422.76M404.74M
Total Liabilities 109.41M422.90M404.77M363.11M329.51M
Shareholder's Equity
Total Debt 19.65M
Common Equity 146.19M96.87M0.11M-77.19M-45.53M
Shareholder's Equity 146.19M96.87M0.11M-77.19M-45.53M
Liabilities and Shareholders Equity 255.59M519.77M404.88M285.92M283.98M
Retained Earnings -162.94M-264.26M-373.14M-471.56M-558.18M